Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for vitamin root_names_name in Any Name (approximate match)

Showing 6831 - 6840 of 7882 results

First page
Previous page
Next page
Next page

BK Virus large T antigen pool of 170 peptides derived from a peptide scan (15mers with 11 aa overlap) through Large T antigen of BK Polyomavirus (BKV)

TL8W7SNX67

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

Glucosylated stevia extract 40% with 14% Rebaudioside A

V6L7S7X863

Status:

Other

Class:

G1 SPECIFIED SUBSTANCE

LUCINACTANT

5BSH2G9BH8

Status:

US Previously Marketed

Source:

SURFAXIN by LEES PHARM HK

(2012)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

First approved in 2012

Source:

SURFAXIN by LEES PHARM HK

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021746

Class:

G1 SPECIFIED SUBSTANCE

LIOTRIX

YW8HJ0N26X

Status:

US Previously Marketed

Source:

THYROLAR-0.25 by ALLERGAN

(1969)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016807

First approved in 1969

Source:

THYROLAR-0.25 by ALLERGAN

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016807

Class:

G1 SPECIFIED SUBSTANCE

PLASMALYTE A

MZD2VV6EW6

Status:

Possibly Marketed Outside US

Source:

BLA125773

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91b0c63a-9a7e-46d0-a562-dc0d7d7867f3

First approved in 2024

Source:

BLA125773

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91b0c63a-9a7e-46d0-a562-dc0d7d7867f3

Class:

G1 SPECIFIED SUBSTANCE

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A

MX37N1DUF3

Status:

Possibly Marketed Outside US

Source:

ANDA216594

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48080efd-1781-4585-83f8-c43957ac63b3

First approved in 2022

Source:

ANDA216594

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48080efd-1781-4585-83f8-c43957ac63b3

Class:

G1 SPECIFIED SUBSTANCE

CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)

59TL3WG5CO

Status:

Possibly Marketed Outside US

Source:

Hexachlor-K by GlenHaven LLC

(2016)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=544b09e6-22da-487e-864f-a40be3872aa9

First approved in 2000

Source:

21 CFR 332

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46996845-9398-41d8-bf99-79f6a29bec28

Class:

G1 SPECIFIED SUBSTANCE

Lunsotogene Parvec

P6ZNU67HPU

Status:

Investigational

Source:

INN:lunsotogene parvec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/P6ZNU67HPU

Class:

CONCEPT

47D11

20YWF2NH7O

Status:

Investigational

Source:

NCT04644120: Phase 1 Interventional Completed CoronaVirus Disease-2019 (COVID-19)

(2020)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04644120

Class:

CONCEPT

AVID-200

6EX05GL2VK

Status:

Investigational

Source:

NCT03895112: Phase 1 Interventional Completed Primary Myelofibrosis

(2019)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT03895112

Class:

CONCEPT

TL8W7SNX67
Not a public record

Concept

BK Virus large T antigen pool of 170 peptides derived from a peptide scan (15mers with 11 aa overlap) through Large T antigen of BK Polyomavirus (BKV)

V6L7S7X863
Not a public record

Concept

Glucosylated stevia extract 40% with 14% Rebaudioside A

Concept

LUCINACTANT

Concept

LIOTRIX

Concept

MX37N1DUF3
Not a public record

Concept

ETHYLCELLULOSE AQUEOUS DISPERSION TYPE A

59TL3WG5CO
Not a public record

Concept

CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)

Concept

Lunsotogene Parvec

Concept

47D11

Concept

AVID-200

Showing 6831 - 6840 of 7882 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1